GIP
CORT icon

Granite Investment Partners’s Corcept Therapeutics CORT Stock Holding History

Granite Investment Partners’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15M Buy
+172,228
New +$10.4M 0.77% 36
2024
Q1 		– Sell
-309,698
Closed -$10.1M – 265
2023
Q4 		$10.1M Sell
309,698
-488,854
-61% -$13.4M 0.39% 81
2023
Q3 		$21.8M Buy
798,552
+6,033
+0.8% +$175K 0.91% 31
2023
Q2 		$17.6M Sell
792,519
-2,557
-0.3% -$58.9K 0.7% 55
2023
Q1 		$17.2M Buy
+795,076
New +$17.4M 0.72% 57

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Granite Investment Partners's CORT Position: Q2 2026 in Review

Granite Investment Partners opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 172,228 shares worth $15M. The stake represents 0.77% of the portfolio and ranks #36 among its holdings. This is a return to the name: Granite Investment Partners previously reported a position in CORT as recently as Q4 2023.

Granite Investment Partners first reported a position in CORT in Q1 2023 and has held it in 5 quarters since. The position peaked at $21.8M in Q3 2023. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Granite Investment Partners held 172,228 shares of Corcept Therapeutics worth $15M as of Q2 2026.
  • Corcept Therapeutics was a new Granite Investment Partners position in Q2 2026.
  • Corcept Therapeutics made up 0.77% of Granite Investment Partners's portfolio in Q2 2026, its #36 holding.
  • Granite Investment Partners first reported a position in Corcept Therapeutics in Q1 2023 and has held it in 5 quarters since.
  • Granite Investment Partners's Corcept Therapeutics position peaked at $21.8M in Q3 2023.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Granite Investment Partners's 13F filing for Q2 2026, filed 7 Aug 2026.